IPO Analysis: Heranba Industries IPO Analysis: Heranba Industries Heranba Industries, a crop protection chemicals manufacturer is coming out with its IPO. Read on to find if you should subscribe to the issue.
IPO analysis: RailTel Corporation of India IPO analysis: RailTel Corporation of India RailTel is a Miniratna (Category- I) central public sector enterprise, which is wholly-owned by the Government of India and comes under the administrative control of the Ministry of Railways. It is hitting the primary capital market with its IPO. Read on to find out whether you should subscribe to the issue or not.
REIT analysis: Brookfield India REIT REIT analysis: Brookfield India REIT Brookfield India REIT is approaching the capital market to raise Rs 3,800 crore. Read onto find out if you should subscribe to the issue.
IPO Analysis: Stove Kraft IPO Analysis: Stove Kraft Stove Kraft, a Bengaluru-based company, engaged in the manufacture & trade of kitchen solutions under Pigeon and Gilma brands, is coming out with its IPO. Read onto find out if you should subscribe to the issue.
IPO Analysis: Home First Finance Company IPO Analysis: Home First Finance Company Home First Finance Company, which targets first time home buyers in the low and middle-income group, is coming out with its IPO. Read on to find if you should subscribe to the issue.
Cipla receives final USFDA approval for Efavirenz Cipla receives final USFDA approval for Efavirenz Nikita Singh / 20-Jun-2018, 04:21 PM / Article rating: 4.3 Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).
Alembic continues rally as Panelav unit receives EIR Alembic continues rally as Panelav unit receives EIR Nikita Singh / 15-Jun-2018, 12:36 PM / Article rating: 3.0 The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association.
Overnight Digest: Stocks to look out for on June 15 Overnight Digest: Stocks to look out for on June 15 Nikita Singh / 14-Jun-2018, 06:33 PM / Article rating: 5.0 The stocks that are likely to record significant movement on the bourses on Friday, June 15 are HIL Limited, Wipro Limited, Maha Rashtra Apex Corporation Limited and Hind Aluminium Industries Limited.
Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Nikita Singh / 14-Jun-2018, 12:52 PM / Article rating: 3.5 The share price of Cipla surged by nearly 2 per cent in the early trade on Thursday as the company received the USFDA approval for Isoproterenol Hydrochloride injection, a generic version of Hospira Inc’s Isuprel injection.
Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Nikita Singh / 14-Jun-2018, 12:29 PM / Article rating: 5.0 Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules.